Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Karyopharm Therapeutics Inc’s stock clocked out at $0.72, up 0.36% from its previous closing price of $0.72. In other words, the price has increased by $0.36 from its previous closing price. On the day, 0.85 million shares were traded. KPTI stock price reached its highest trading level at $0.76 during the session, while it also had its lowest trading level at $0.6661.
Ratios:
To gain a deeper understanding of KPTI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Paulson Richard A. sold 4,055 shares for $0.78 per share. The transaction valued at 3,175 led to the insider holds 1,124,257 shares of the business.
Paulson Richard A. sold 3,620 shares of KPTI for $2,932 on Dec 04 ’24. The President and CEO now owns 1,128,312 shares after completing the transaction at $0.81 per share. On Nov 05 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,675 shares for $0.91 each. As a result, the insider received 3,346 and left with 1,131,932 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 90680848 and an Enterprise Value of 224284000. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61. Its current Enterprise Value per Revenue stands at 1.511 whereas that against EBITDA is -1.785.
Stock Price History:
The Beta on a monthly basis for KPTI is 0.06, which has changed by -0.0082758665 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -8.26%, while the 200-Day Moving Average is calculated to be -21.52%.
Shares Statistics:
It appears that KPTI traded 935.36K shares on average per day over the past three months and 1261050 shares per day over the past ten days. A total of 125.30M shares are outstanding, with a floating share count of 115.36M. Insiders hold about 8.58% of the company’s shares, while institutions hold 47.15% stake in the company. Shares short for KPTI as of 1734048000 were 19792052 with a Short Ratio of 20.81, compared to 1731628800 on 18934223. Therefore, it implies a Short% of Shares Outstanding of 19792052 and a Short% of Float of 15.8.
